Boston Scientific Tries To Settle Guidant Claims

Law360, New York (May 17, 2007, 12:00 AM EDT) -- Boston Scientific Corp. is in negotiations to settle approximately 1,350 product liability suits it took on when it beat out Johnson & Johnson last year for the right to acquire Guidant Corp. for around $27 billion, published reports say.

On Thursday, the Wall Street Journal reported that Boston Scientific was in talks to resolve the Guidant claims, which accuse Guidant of selling implantable defibrillators despite being aware of defects in the devices. The Journal also reported that Boston Scientific had set aside reserves of $732 million...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.